环孢菌素 C

环孢菌素 C性质、用途与生产工艺

应用

环孢菌素 C是一种抗生素，作为有机合成中间体和医药中间体，可用于实验室研发过程和化工生产过程中。

生物活性

Cyclosporin C 是一种真菌代谢物，在炎症性 T. inflatum 中发现，具有多种生物活性，包括抗真菌、抗病毒和免疫抑制特性。Cyclosporin C 对灰霉病杆菌、黑曲霉、链格孢菌、毛霉和青霉的分离株 (MICs=0.1-5 μg/ml) 具有活性。

环孢菌素 C 上下游产品信息

上游原料

下游产品

环孢菌素 C 生产厂家

 

59787-61-0, 环孢菌素 C 相关搜索:

• ACTIVE PHARMACEUTICAL INGREDIENTS
• Pharmaceuticals
• Peptides
• Intermediates & Fine Chemicals
• 抑制剂
• 其它杂质
• 标准品
• 杂质对照品
• 化学试剂
• 医药原料
• 医药原料药 科研原料
• 分析试剂-对照品
• 医用原料
• 杂质
• 对照品
• 原料药
• 医药原料药
• 免疫抑制剂
• 微生物代谢物
• C62H111N11O13
• 59767-61-0
• 69787-61-0
• 化合物：Cyclosporin C
• 源叶 S31059 环孢菌素C
• 源叶 S31059 环孢菌素C
• 化合物:Cyclosporin C
• 环孢菌素杂质3(环孢菌素C)
• 环孢素C(EP)
• 环孢菌素C/环孢素C
• (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-33-((1R,2R,E)-1-羟基-2-甲基己-4-烯-1-基-30-((R)-1-羟乙基)-6,9,18,18,24-四异丁基丁基-3,21-二异丙基-1,4,7,10,12,15,19,25,28-壬甲基-1,4,7,10,13,16,19,22,25,28,31-十一氮杂环三十三烷-2,5,8,11,14,17,20,23,26,29,32-十一酮
• 环孢素杂质C
• 环孢霉素杂质C
• 环孢素杂质3
• 环孢菌素杂质C
• 环孢霉素C
• 环胞霉素 C
• 环[L-丙氨酰-D-丙氨酰-N-甲基-L-亮氨酰-N-甲基-L-亮氨酰-N-甲基-L-缬氨酰-3-羟基-N,4-二甲基-L-2-氨基-6-辛烯酰-L-苏氨酰-N-甲基甘氨酰-N-甲基-L-亮氨酰-L-缬氨酰-N-甲基-L-亮氨酰]
• 环孢菌素C
• 环孢素C
• 59787-61-0
• (3R,6S,9S,12R,15R,18S,21R,24S,30R,33S)-30-(1-Hydroxyethyl)-33-(1-hydroxy-2-methylhex-4-enyl)-1,4,7,10,12,15,19,25,28-nomethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
• (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-30-[(1R)-1-hydroxyethyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone
• Cyclosporin C, EvoPure?
• (3R,6S,9S,12R,15R,18S,21R,24S,30R,33S)-30-(1-Hydroxyethyl)-33-(1-hydroxy-2-methylhex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
• (3R,6S,9S,12R,15R,18S,21R,24S,30R,33S)-30-(1-Hydroxyethyl)-33-(1-hydroxy-2-methylhex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,1
• (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-33-((1R,2R,E)-1-Hydroxy-2-methylhex-4-en-1-yl)-30-((R)-1-hydroxyethyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone
• Cyclosporine Impurity 3
• Cyclosporin A, 7-L-threonine-
• Cyclosporin Impurity 3(Cyclosporin C)
• Cyclosporin Impurity C
• CL246
• Cyclosporin C, >=95%
• 7-Threonine-cyclosporin A
• 7-L-Threoninecyclosporin A, WF 3484
• Cyclosporine IMpurity-C
• 7-L-Threoninecyclosporin A
• WF-3484
• (3R,4R)-3-Hydroxy-N-methyl-5-[(E)-1-propenyl]-cyclo(L-Leu-L-Thr-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-)